Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BOT | Ann: BOT NTA 09-05-2024 $4.97691 | 10/05/24 | 0 | 26 | |||
|
|||||||
BOT | Ann: BOT Fund Update - 31 March 2024 | 10/05/24 | 0 | 31 | |||
|
|||||||
BOT | Ann: BOT NTA 08-05-2024 $5.00387 | 09/05/24 | 0 | 25 | |||
|
|||||||
BOT | Ann: BOT NTA 07-05-2024 $4.93314 | 08/05/24 | 0 | 41 | |||
|
|||||||
BOT | Ann: BOT NTA 06-05-2024 $4.93091 | 07/05/24 | 0 | 54 | |||
|
|||||||
BOT | Ann: BOT NTA 03-05-2024 $4.90779 | 06/05/24 | 0 | 36 | |||
|
|||||||
BOT | Ann: BOT NTA 02-05-2024 $4.88077 | 03/05/24 | 0 | 39 | |||
|
|||||||
BOT | Ann: BOT NTA 01-05-2024 $4.94660 | 02/05/24 | 0 | 40 | |||
|
See All Discussions